35th Annual Meeting & Expo of the Controlled Release Society
July 12-16, 2008
New York, NY

JMP Securities Healthcare Focus Conference
Oct. 6-7, 2008
New York, NY

7th Annual BIO InvestorForum
Oct. 29-31, 2008
San Francisco, CA

AAO Annual Meeting
Nov. 8-11, 2008
Atlanta, GA

Acumen BioFin Rodman and Renshaw 10th Annual Healthcare Conference
Nov. 10-12, 2008
New York, NY

7/15/08
EyeGate Pharma Initiates Landmark Clinical Study Employing the
EyeGate® II Non-Invasive Ocular Delivery System in Acute Anterior Uveitis

6/16/08
EyeGate Pharma Appoints Amy Cohen As Vice President, Clinical Operations

6/11/08
EyeGate Pharma to Present at Upcoming Biotechnology Industry Conferences

6/09/08
EyeGate Pharma Adds Drug Development and Delivery Expert,
Praveen Tyle, to its Board of Directors

4/24/08
EyeGate Pharma to Present Data on the EyeGate II Ophthalmic
Delivery System at ARVO 2008 Annual Meeting

4/15/08
EyeGate Pharma to Present at Upcoming Investor Conferences

4/14/08
EyeGate Pharma Initiates Phase I Study of EyeGate II Delivery System

3/21/08
Michael Patane Featured in Mass High Tech's "The Mover" Section

3/12/08
EyeGate Pharma Secures $15M in Series C Venture Funding

1/23/08
EyeGate Pharma Appoints Michael A. Patane to Chief Scientific Officer

1/17/08
EyeGate Pharma Featured in Drug Delivery Technology's Specialty Pharma Section

• 12/20/07
  EyeGate Pharma Appoints Remis Bistras as Vice President, Business Development
• 10/29/07
  EyeGate Pharma’s CEO to Participate at Upcoming Investor and Ophthalmology Conferences
• 09/25/07
  EyeGate Pharma to Present at BIO InvestorForum 2007
• 09/05/07
  EyeGate Pharma to Showcase EyeGate II Delivery System to Inflammatory Ocular Disease Specialists at IOIS Congress
• 08/29/07
  EyeGate Pharma Adds Paul Chaney to Board of Directors; Prepares for Clinical Operations
• 07/25/07
  EyeGate Pharma Announces Executive Appointments
• 06/20/07
  EyeGate Pharma Appoints Richard Guy to Scientific Advisory Board and Announces Collaborative Research Agreement with University of Bath
• 04/24/07
  EyeGate Pharma to Present at 2007 BIO International Convention and ARVO
• 04/11/07
  EyeGate Pharma to Present at IBC's International Conference on Ocular Anti-Angiogenesis
• 02/06/07
  EyeGate Pharma to Present at the 9th Annual BIO CEO & Investor Conference
• 01/17/07
  EyeGate Pharma Closes $12M Series B Venture Financing

• 11/02/06
  EyeGate Pharma Secures $10M in Series B Venture Funding
• 10/30/06
  EyeGate Pharma Starts U.S. Operations in Waltham, MA

Click to View Full Article

Click to View Full Article